GM expected to start cutting 4,000 white-collar workers Monday

General Motors is expected to start its next round of white-collar job cuts Monday, but the carmaker apparently has fewer staff reductions left to make than has been anticipated.

In November, GM said it needed to reduce its North American white-collar workforce by about 8,000. About 2,250 salaried workers volunteered to take a buyout, leaving as many as 5,750 workers still to be cut.

But on Friday a GM spokesman said the automaker had trimmed about 1,500 contract jobs, meaning about 4,000 more staff jobs will be cut.

As to when those workers will be served pink slips, GM won't say, beyond, "We’ve indicated that the involuntary reductions would happen in the first quarter," said Pat Morrissey, GM spokesman.


https://www.google.com/amp/s/amp.freep.com/amp/2743506002

Freshman Katie Hill adjusting to those East Coast-West Coast commutes

HI-02: Hawaii state Sen. Kai Kahele will run for Tulsi Gabbard's seat

Hawaii state Sen. Kai Kahele officially announced today that he plans to run for the congressional seat occupied by U.S. Rep. Tulsi Gabbard, setting up a potential 2020 Democratic primary challenge for Gabbard early on as she embarks on her bid for president. The congressional seat represents the neighbor islands and rural Oahu.

Kahele made his announcement at the Moʻoheau Bandstand in downtown Hilo, where Hawaii’s Democratic Party rallies every election. He was surrounded by his family, including wife and two children, and supporters. Former state Sen. Brickwood Galuteria moderated the event. State Sen. Lorraine Inouye (D-Kaupulehu-Waimea-North Hilo) also attended.

Announcing on Martin Luther King Jr. Day, Kahele referenced the late leader of the Civil Rights movement’s dedication to social and economic justice as inspiration for his congressional run, quoting King: “Lifeʻs most persistent and urgent question is, What are you doing for others?”

https://www.staradvertiser.com/2019/01/21/breaking-news/hawaii-sen-kai-kahele-officially-announces-2020-bid-for-congress/#googDisableSync

AOC: The public, not pharma, funds drug research.